Diagnostic and laboratory data is the most reliable signal of where demand is forming in precision medicine, and the hardest to get at. Hyperdrive resolves that data, builds the platforms that put it to work, and helps commercial teams turn it into pipeline. Our people come from diagnostics, precision medicine and sales enablement.
153K
Specialty providers indexed
6M+
Test results a year
5M+
Digital whole slide images
Everything we do runs on the same foundation: resolved diagnostic data and the systems that make it usable.
Data network
A select group of clinical, pathology and genomics laboratories supplying data directly. Partner labs turn what they already produce into revenue and a durable enterprise asset.
Join the network
Custom builds
When the system you need does not exist yet, we build it with you — running under your brand, on your data, for your customers.
See BioSpecimen360
Advisory
For teams who need the thinking before the build. Custom real-world data workshops and commercial data strategy, working through what your data can support and what it would take to close the gap.
More on advisory
Find the providers who already have treatment-eligible patients, and the community gaps where testing is not happening at all.
For biopharma
Monetize the data you already produce, and give your sales team lists that match your ideal customer profile.
For reference labs
Know what each lab can run, and reach the pathologists who decide and influence what gets adopted.
For diagnostics
Boca Bio needed a way for researchers to search a biospecimen catalog the way a buyer actually thinks about it: by sample type, matrix, test characterization and the assay results attached to each specimen.
We collaborated with Boca Bio to build BioSpecimen360, which runs as their own branded product with Hyperdrive as the trusted technology partner. Over 360,000 banked biospecimens are available for purchase on the platform today. The same resolution and enrichment work behind Voyager, applied to a different problem.
The hard part in this space is rarely the software. It is that provider identity is messy, laboratory data does not arrive in a standard shape, and the commercial question underneath is usually more specific than any off-the-shelf product allows for. Those are the problems we like.
Our team works in diagnostics, precision medicine and sales enablement every day. We know what a pathology report contains, what an NPI does and does not tell you, and what a field team needs in order to act on a Monday morning. Engagements start from that fluency rather than building toward it.
Working sessions built around your data and your commercial question, not a general overview of the RWD landscape. What the data can answer today, where the gaps are, and what closing them is worth.
Reference laboratory
A national oncology reference laboratory had begun bringing TEFCA HIE data into their warehouse. We ran a strategy workshop that walked their team through a prioritization matrix of the valuable problems that data asset could solve, and where to put it to work across the enterprise for informatics revenue.
Digital pathology
A leading digital pathology company wanted to turn their sourced network data into data services revenue. We ran a workshop on how pharma buys laboratory data for alerts and triggers, then gave them clear next steps to operationalize it quickly, org charts and selling motion included.
Go-to-market
Diagnostics startups and reference laboratories looking to grow into new markets. Go-to-market strategy work on where the demand actually sits, which accounts to pursue first, and what it takes to reach them.
If it is Voyager, give us a brand and a geography and we will run it live against real accounts and providers, on data you can check. The target list we build on the call is yours to keep. If it is a build, or a question about what your data can support, the conversation starts the same way.